Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 276

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 276
---
 for the 2025 Annual Meeting of Stockholders, to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024, and is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

The information required by this item will be included in our Proxy Statement for the 2025 Annual Meeting of Stockholders, to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024, and is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services.

The information required by this item will be included in our Proxy Statement for the 2025 Annual Meeting of Stockholders, to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024, and is incorporated herein by reference.

127

PART IV

Item 15. Exhibits, Financial Statement Schedules.

(1)	Financial Statements:

The financial statements required by Item 15(a) are filed as part of this Annual Report on Form 10-K under Item 8 “Financial Statements and Supplementary Data.”

(2)	Financial Statement Schedules

The financial statement schedules required by Item 15(a) are omitted because they are not applicable, not required or the required information is included in the financial statements or notes thereto as filed in Item 8 of this Annual Report on Form 10-K.

(3)	Exhibits.

    ExhibitNumber
       
    Description
        
    Form
         
    File No.
        
    ExhibitFilingDate
        
    Filed/ FurnishedHerewith

    3.1
     
    Restated Certificate of Incorporation, dated June 1, 2021, as amended June 22, 2023.
     
    10-Q
     
    001-40431
     
    August 7, 2023

    3.2
     
    Amended and Restated Bylaws, dated February 17, 2023.
     
    8-K
     
    001-40431
     
    February 23, 2023

    3.3
     
    Certificate of Ownership and Merger, dated December 23, 2021
     
    10-K
     
     001-40431
     
    March 7, 2022

    4.1
     
    Form of Common Stock Certificate
     
    S-1/A
     
    333-